Valuation: Proteome Sciences plc

Market Cap 5.7M 7.61M 6.65M 6.11M 10.81M 725M 10.97M 73.4M 28.54M 356M 28.57M 27.95M 1.23B P/E 2024
-2.95x
P/E 2025 -2.4x
Enterprise Value 20.69M 27.63M 24.15M 22.2M 39.24M 2.63B 39.83M 266M 104M 1.29B 104M 101M 4.46B EV / Sales 2024
4.79x
EV / Sales 2025 5.96x
Free-Float
81.91%
Yield 2024 *
-
Yield 2025 -
1 day-1.52%
1 week-5.25%
Current month-1.52%
1 month-9.97%
3 months+2.85%
6 months-42.98%
Current year-35.00%
1 week 1.3
Extreme 1.3
2.3
1 month 1.3
Extreme 1.3
2.3
Current year 1.2
Extreme 1.2
4.4
1 year 1.2
Extreme 1.2
4.4
3 years 1.2
Extreme 1.2
8.71
5 years 1.2
Extreme 1.2
8.79
10 years 1.2
Extreme 1.2
20.25
Manager TitleAgeSince
Corporate Officer/Principal - 01/04/2017
Corporate Secretary - 01/08/2017
Director TitleAgeSince
Chairman 73 30/06/2014
Director/Board Member 62 01/01/2010
Director/Board Member 71 01/07/2014
Date Insider Type Main position Quantity % Market Cap.
14/04/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
14/04/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
06/04/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
Change 5-day change 1-year change 3-year change Capi.($)
-1.52%-5.25%-46.55%-79.75% 7.61M
+3.49%+1.36%-29.04%-11.02% 166B
+5.04%+2.73%-5.88%-4.53% 106B
+2.80%+3.63%+0.09%+55.31% 57.69B
+1.33%+1.39%+55.88%+50.01% 53.78B
+3.39%+1.39%-10.26%-39.65% 43.56B
+3.50%+11.11% - - 36.52B
+3.47%+1.58%-14.08%-43.91% 27.49B
+0.20%+4.24%+64.56%-3.33% 25.84B
+2.78%+1.17%-8.15%-0.43% 21.27B
Average +2.45%+3.68%+0.73%-8.59% 53.88B
Weighted average by Cap. +3.31%+3.80%-3.55%+1.07%

Financials

2024 2025
Net sales 4.89M 6.53M 5.71M 5.24M 9.27M 621M 9.41M 62.94M 24.47M 305M 24.5M 23.97M 1.05B 3.76M 5.02M 4.38M 4.03M 7.12M 478M 7.23M 48.38M 18.81M 235M 18.83M 18.42M 809M
Net income -3.41M -4.55M -3.98M -3.65M -6.46M -433M -6.56M -43.87M -17.05M -213M -17.07M -16.71M -734M -3.06M -4.09M -3.57M -3.28M -5.81M -389M -5.89M -39.42M -15.33M -191M -15.34M -15.01M -659M
Net Debt 13.39M 17.89M 15.64M 14.37M 25.4M 1.7B 25.79M 173M 67.06M 837M 67.14M 65.7M 2.88B 14.99M 20.02M 17.5M 16.08M 28.43M 1.91B 28.86M 193M 75.05M 937M 75.13M 73.52M 3.23B
Logo Proteome Sciences plc
Proteome Sciences plc is a specialist provider of contract proteomics services. The Company’s services enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. Its principal activities involve protein biomarker research and development. It uses high-sensitivity techniques to detect and characterize differentially expressed proteins in biological samples for diagnostic, prognostic and therapeutic applications. SysQuant and TMT MS2 are unbiased methods for identifying and contextualizing new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibrator provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. In addition, it has invented and developed the technology for TMT and TMTpro, and manufactures these small, protein-reactive chemical reagents for multiplex quantitative proteomics.
Employees
32
Date Price Change Volume
03/07/26 GBX 1.625 -1.52% 350,311
02/07/26 GBX 1.650 0.00% 2
01/07/26 GBX 1.650 0.00% 29,546
30/06/26 GBX 1.650 -8.33% 54,141
29/06/26 GBX 1.800 +4.96% 486,345